ICD-10-CM: 2/21/2012
The 1
Hematopoietic
Codes
ICD-10-CM Implementation Team
for Cancer Registrars
Presenters:
Jennifer Ruhl, RHIT, CCS, CTR (NCI/SEER)
Jim Hofferkamp, CTR (NAACCR)
February 22, 2012
Overview of Presentation
Introduction
ICD-9-CM Categories
ICD-10-CM Categories/ Subcategories
Review of Coding Systems (by WHO
category classification)
Review of Hematopoietic coding
(based on Hematopoietic Rules and
Database)
Advantages of ICD-10-CM for
Hematopoietic coding
More subcategories for
hematopoietic coding
More specified histologies listed
as inclusion terms
Makes it easier for medical coders
to determine best code
More one to one conversions to
ICD-O-3 hematopoietic histologies
Organization of Code System 2/21/2012
2
ICD-10-CM has 3 –7 characters, and are
not case sensitive
• Character 1 is alpha (all letters are used,
except U)
• Character 2 is numeric
• Characters 3 –7 are alpha or numeric
– I10 – Essential (primary) hypertension
– A69.20 – Lyme disease, unspecified
ICD-9-CM to ICD-10-CM
ICD-9-CM Categories Subcategories
Example 11 66
ICD-10-CM 203
Example 17 203.0
C90 113
C90.0
ICD-O-3 and ICD-10-CM
C42.1 does not exist in ICD-10-CM
C77 codes are for metastatic
lymph node involvement, not for
lymphomas
ICD-9-CM Categories 2/21/2012
3
Diffuse Non-Hodgkin’s lymphoma
Hodgkin’s disease
Other malignant neoplasm of
lymphoid and histiocytic tissue
Multiple Myeloma and other
Immunoproliferative diseases
ICD-9-CM Categories
Lymphoid Leukemia
Myeloid Leukemia
Monocytic Leukemia
Other specified Leukemia
Leukemia of unspecified cell type
Polycythemia vera
Myelodysplastic syndromes
ICD-10-CM CATEGORIES
THE LYMPHOMAS
Lymphomas: The 5th character 2/21/2012
4
0 – Unspecified site
1 – Lymph nodes of head, face, neck
2 – Intrathoracic lymph nodes
3 - Intra-abdominal lymph nodes
4 – Lymph nodes of axilla and upper
limb
5 – Lymph nodes of inguinal region
and lower limb
Lymphomas: The 5th character
6 – Intrapelvic nodes
7 – Spleen
8 – Lymph nodes of multiple sites
9 – Extranodal and solid organ sites
Note: Categories with a fifth character will
have a “_” after the number
ICD-10-CM Structure
Diffuse large B-cell lymphoma
confined to the axillary lymph
nodes
C83.34
Axillary lymph nodes (5th character location)
Diffuse large B-cell lymphoma (subcategory)
Non-follicular lymphoma (category)
Lymphoma 5th character : ICD-10- 2/21/2012
CM compared to ICD-O-3 5
Description ICD-10-CM 5th ICD-O-3
character
Lymph nodes of head, face and neck 1 C77.0
Intrathoracic lymph nodes 2 C77.1
Intra-abdominal lymph nodes 3 C77.2
Lymph nodes of axilla or arm 4 C77.3
Lymph nodes of inguinal region or leg 5 C77.4
Pelvic lymph nodes 6 C77.5
Lymphoma 5th character: ICD-10-
CM compared to ICD-O-3
Description ICD-10-CM ICD-O-3
5th character
Lymph nodes of multiple regions
Lymph node, NOS 8 C77.8
Spleen
Unspecified site 0 C77.9
Specified organ
7 C42.2
0 C80.9
9 Primary
site
ICD-10-CM Categories
Hodgkin disease
C81.0_ – Nodular lymphocyte predominant
C81.1_ – Nodular sclerosis
C81.2_ – Mixed cellularity
C81.3_ – Lymphocyte depleted
C81.4_ – Lymphocyte rich
C81.7_ – Other classical Hodgkin
C81.9_ – Unspecified
ICD-10-CM Categories 2/21/2012
6
Follicular [Nodular] non-Hodgkin’s
lymphoma
C82.0_ – Grade I
C82.1_ – Grade II
C82.2_ – Grade III, unspecified
C82.3_ – Grade IIIa
C82.4_ – Grade IIIb
C82.5_ – Diffuse follicle center
C82.6_ – Cutaneous follicle center
C82.8_ – Other types of follicular
C82.9_ – Unspecified follicular
Coding Moment
Patient presents with a enlarged
right cervical lymph node. A
biopsy is done and confirms grade
3 follicular lymphoma. Additional
staging work-up was negative for
any further disease.
• What would ICD-10-CM code would be
assigned to this case?
• What would we assign as ICD O 3 site
and histology?
Coding Moment
We would assign… Follicular lymphoma
C82.2_
C82.0_ – Grade I
C82.1_ – Grade II
C82.2_ – Grade III, unspecified
C82.3_ – Grade IIIa
C82.4_ – Grade IIIb
C82.5_ – Diffuse follicle center
C82.6_ – Cutaneous follicle center
C82.8_ – Other types of follicular
C82.9_ – Unspecified follicular
Coding Moment 2/21/2012
7
The last character is…
1 0 – Unspecified site
The final ICD 10cm 1 – Lymph nodes of head, face, neck
code is… 2 – Intrathoracic lymph nodes
C82.21 3 - Intra-abdominal lymph nodes
4 – Lymph nodes of axilla and upper
The final ICD O 3 code
is… limb
5 – Lymph nodes of inguinal region and
C77.0
9698/3 lower limb
6 – Intrapelvic nodes
7 – Spleen
8 – Lymph nodes of multiple sites
9 – Extranodal and solid organ sites
ICD-10-CM Categories
Non-follicular lymphoma
C83.0_ – Small cell B-cell lymphoma
– Lymphoplasmacytic lymphoma
– Nodal marginal zone lymphoma
– Non-leukemic variant of B-CLL
– Splenic marginal zone lymphoma
C83.1_ – Mantle cell lymphoma
ICD-10-CM Categories
Non-follicular lymphoma
C83.3_ – Diffuse large B-cell lymphoma
– Anaplastic diffuse large B-cell lymphoma
– CD30-positive diffuse large B-cell lymphoma
– Centroblastic diffuse large B-cell lymphoma
– Diffuse large B-cell lymphoma, subtype not specified
– Immunoblastic diffuse large B-cell lymphoma
– Plasmablastic diffuse large B-cell lymphoma
– Diffuse large B-cell lymphoma, subtype not specified
– T-cell rich diffuse large B-cell lymphoma
ICD-10-CM Categories 2/21/2012
8
Non-follicular lymphoma
C83.5_ – Lymphoblastic (diffuse)
– B-precursor lymphoma
– Lymphoblastic B-cell lymphoma
– Lymphoblastic lymphoma NOS
– Lymphoblastic T-cell lymphoma
– T-precursor lymphoma
C83.7_ – Burkitt lymphoma
ICD-10-CM Categories
Non-follicular lymphoma
C83.8_ – Other non-follicular lymphoma
– Intravascular large B-cell lymphoma
– Lymphoid granulomatosis
– Primary effusion B-cell lymphoma
C83.9_ – Non-follicular lymphoma
(diffuse), unspecified
ICD-10-CM Categories
Mature T/NK-cell lymphomas
C84.0_ – Mycosis Fungoides
C84.1_ – Sezary’s disease
C84.4_ – Peripheral T-cell lymphoma,
not specified
C84.6_ – Anaplastic large cell
lymphoma, ALK positive
C84.7_ – Anaplastic large cell
lymphoma, ALK positive
ICD-10-CM Categories 2/21/2012
9
Mature T/NK-cell lymphomas
C84.A_ – Cutaneous T-cell lymphoma,
unspecified
C84.Z_ – Other mature T/NK-cell
lymphomas
C84.9_ – Mature T/NK-cell lymphoma,
unspecified
ICD-10-CM Categories
Other/unspecified B-cell lymphomas
C85.1_ – Unspecified B-cell lymphoma
C85.2_ – Mediastinal (thymic) large B-cell
lymphoma
C85.8_ – Other specified types of NHL
C85.9_ – NHL, unspecified
– Lymphoma, NOS
– Malignant lymphoma, NOS
– Non-Hodgkin lymphoma, NOS
ICD-10-CM Categories
Other specified T/NK-cell lymphomas
C86.0 – Extranodal NK/T-cell lymphoma
C86.1 – Hepatosplenic T-cell lymphoma (9716/3)
C86.2 – Enteropathy-type (intestinal) T-cell
lymphoma
C86.3 – Subcutaneous panniculitis-like T-cell
lymphoma
ICD-10-CM Categories 2/21/2012
10
Other specified T/NK-cell lymphomas
C86.4 – Blastic NK-cell lymphoma
C86.5 – Angioimmunoblastic T-cell lymphoma
C86.6 – Primary cutaneous CD30+ T-cell
proliferations
Note: no fifth character “location” code for C86
ICD-10-CM Categories
Malignant immunoproliferative
diseases and certain other B-cell
lymphomas
C88.0 – Waldenstrom macroglobulinemia
C88.2 – Heavy chain disease
C88.3 – Immunoproliferative small intestinal
disease
C88.4 – Extranodal marginal zone lymphoma
(MALT)
ICD-10-CM Categories
Malignant immunoproliferative
diseases and certain other B-cell
lymphomas
C88.8 – Other immunoproliferative diseases
C88.9 – Malignant immunoproliferative disease,
NOS
Note: no fifth character “location” code for C88
Leukemia & Immunoproliferative 2/21/2012
5th character 11
Description ICD-10-CM
5th
Not having achieved
remission/ failed remission character
In remission 0
In relapse
1
2
ICD-10-CM Categories
Multiple myeloma and malignant
plasma cell neoplasms
C90.0_ Multiple myeloma
C90.1_ Plasma cell leukemia
C90.2_ Extramedullary plasmacytoma
C90.3_ Solitary plasmacytoma
Coding Moment
A patient presents the ER with
severe back pain. While at your
facility he is diagnosed with
multiple myeloma. He is referred
to an oncologist and discharged.
• What would ICD-10-CM code would be
assigned to this case?
• What would we assign as ICD O 3 site
and histology?
Coding Moment 2/21/2012
12
We would assign… Multiple myeloma
C90.0
• C90.0_ Multiple myeloma
• C90.1_ Plasma cell leukemia
• C90.2_ Extramedullary
plasmacytoma
• C90.3_ Solitary plasmacytoma
Coding Moment
The fifth Character
would be…
0
The ICD-10-CM code
would be…
C90.00
The ICD O 3 code
would be…
C42.1
9732/3
ICD-10-CM Categories
Lymphoid Leukemias
C91.0_ Acute lymphoblastic leukemia [ALL]
C91.1_ Chronic lymphocytic leukemia of B-cell
type
C91.3_ Prolymphocytic leukemia of B-cell type
C91.4_ Hairy Cell Leukemia
C91.5_ Adult T-cell lymphoma/leukemia (HTLV-
1-associated)
ICD-10-CM Categories 2/21/2012
13
Lymphoid Leukemias
C91.6_ Prolymphocytic leukemia of T-cell type
C91.A_ Mature B-cell leukemia Burkitt-type
C91.Z_ Other lymphoid leukemia
C91.9_ Lymphoid leukemia, unspecified
Coding Moment
Patient presents with a single
enlarged cervical lymph node and
is diagnosed chronic B-cell
lymphocytic leukemia without
remission. Imaging did not
indicate any additional disease.
Patient was referred to and
oncologist and discharged.
Coding Moment
What would be the ICD-10-CM
code?
• C91.10
What would be the ICD-O-3 code?
• If no further information is available,
code to C77.0 and 9670/3 per PH 10.
• This could change if we find additional
information
ICD-10-CM Categories 2/21/2012
14
Myeloid Leukemias
C92.0_ Acute myeloblastic leukemia
C92.1_ Chronic myeloid leukemia, BCR/ABL-
positive
C92.2_ Atypical chronic myeloid leukemia,
BCR/ABL-negative
C92.3_ Myeloid Sarcoma
C92.4_ Acute promyelocytic leukemia
ICD-10-CM Categories
Myeloid Leukemias
C92.5_ Acute myelomonocytic leukemia
C92.6_ Acute myeloid leukemia with 11q23-
abnormality
C92.A_ Acute myeloid leukemia with
multilineage dysplastic
C92.Z_ Other myeloid leukemia
C92.9_ Myeloid leukemia, unspecified
ICD-10-CM Categories
Monocytic Leukemia
C93.0_ Acute monoblastic/monocytic leukemia
C93.1_ Chronic myelomonocytic leukemia
C93.3_ Juvenile myelomonocytic leukemia
C93.Z_ Other monocytic leukemia
C93.9_ Monocytic leukemia, unspecified
ICD-10-CM Categories 2/21/2012
15
Other Leukemias of specified cell type
C94.0_ Acute erythroid leukemia
C94.2_ Acute megakarybolastic leukemia
C94.3_ Mast cell leukemia
C94.4_ Acute panmyelosis with myelofibrosis
C94.6_ Myelodysplastic disease, not classified
ICD-10-CM Categories
Other Leukemias of specified cell type
C94.6_ Myelodysplastic disease, not classified
This is not to be confused with “myelodysplastic
disorder”
C94.8_ Other specified Leukemias
Aggressive NK-cell leukemia
Acute basophilic leukemia
ICD-10-CM Categories
Leukemia of unspecified cell type
C95.0_ Acute leukemia of unspecified cell type
Acute leukemia, NOS
Biphenotypic acute leukemia
C95.1_ Chronic leukemia of unspecified cell type
– Chronic leukemia, NOS
C95.9_ Leukemia, unspecified
– Leukemia, NOS
ICD-10-CM Categories 2/21/2012
16
Other and unspecified malignant
neoplasms of lymphoid, hematopoietic
and related tissue
C96.0 Multifocal and multisystemic
(disseminated) Langerhans-cell histiocytosis
– Histiocytosis X, multisystemic
– Letterer-Siwe disease
C96.2 Malignant mast cell tumor/mast cell
sarcoma
C96.4 Sarcoma of dendritic cells
– Follicular/ interdigitating/Langerhans cell sarcoma
ICD-10-CM Categories
Other and unspecified malignant
neoplasms of lymphoid, hematopoietic
and related tissue
C96.5 Multifocal and unisystemic Langerhans-
cell histiocytosis
C96.6 Unifocal Langerhans-cell histiocytosis
C96.A Histiocytic sarcoma
C96.Z Other specified malignant neoplasms of
lymphoid, hematopoietic and related tissue
C96.9 Malignant neoplasm of lymphoid,
hematopoietic and related tissue, unspecified
ICD-10-CM Categories
Other and unspecified malignant
neoplasms of lymphoid, hematopoietic
and related tissue
C96.5 Multifocal and unisystemic Langerhans-
cell histiocytosis
C96.6 Unifocal Langerhans-cell histiocytosis
C96.A Histiocytic sarcoma
C96.Z Other specified malignant neoplasms of
lymphoid, hematopoietic and related tissue
C96.9 Malignant neoplasm of lymphoid,
hematopoietic and related tissue, unspecified
ICD-10-CM Categories 2/21/2012
17
Polycythemia Vera
D45: Polycythemia vera
ICD-10-CM Categories
Myelodysplastic syndromes
D46.0 Refractory anemia without ring
sideroblasts, so stated
D46.1 Refractory anemia with ring sideroblasts
D46.20 Refractory anemia with excess of blasts,
unspecified (RAEB NOS)
D46.21 Refractory anemia with excess of blasts,
1 (RAEB 1)
D46.22 Refractory anemia with excess of blasts
2 (RAEB 2)
ICD-10-CM Categories
Myelodysplastic syndromes
D46.A Refractory cytopenia with multilineage
dysplasia
D46.B Refractory cytopenia with multilineage
dysplasia and ring sideroblasts
D46.C Myelodysplastic syndrome with isolated
del (5q) chromosomal abnormality
D46.4 Refractory anemia, unspecified
D46.Z Other myelodysplastic syndromes
D46.9 Myelodysplastic syndrome, unspecified
Myelodysplasia NOS
ICD-10-CM Categories 2/21/2012
18
Other neoplasms of uncertain behavior
of lymphoid, hematopoietic and related
tissue
D47.0 Histiocytic and mast cell tumors of
uncertain behavior
D47.1 Chronic myeloproliferative disease
– Chronic neutrophilic leukemia
– Myeloproliferative disease, unspecified
D47.2 Monoclonal gammopathy [MGUS]
ICD-10-CM Categories
Other neoplasms of uncertain behavior
of lymphoid, hematopoietic and related
tissue
D47.3 Essential (hemorrhagic)
thrombocythemia
– Essential thrombocytosis
– Idiopathic hemorrhagic thrombocythemia
D47.4 Osteomyelofibrosis
– Chronic idiopathic myelofibrosis
– Myelofibrosis (idiopathic)(with myeloid metaplasia)
– Myelosclerosis (megakaryocytic) ( with myeloid
metaplasia)
ICD-10-CM Categories
Other neoplasms of uncertain behavior
of lymphoid, hematopoietic and related
tissue
D47.Z1 Post-transplant lymphoproliferative
disorder (PTLD)
D47.Z9 Other specified neoplasms of uncertain
behavior of lymphoid, hematopoietic and
related tissues
D47.9 Neoplasm of uncertain behavior of
lymphoid, hematopoietic and related tissue,
unspecified
COMPARISON OF ICD-O-3 2/21/2012
HEMATOPOIETIC HISTOLOGIES (9590- 19
9992) TO ICD-9-CM, ICD-10 (CAUSE OF
DEATH CODING) AND ICD-10-CM
WHO CATEGORIES
Myeloproliferative Neoplasms
(Table B1)
ICD-O-3 Code and Histology ICD-9- ICD- ICD-
CM 10 10-CM
9740 Mast cell sarcoma
9741 Systemic mastocytosis 202.6_ C96.2 C96.2
9742 Mast cell leukemia 202.6_ C96.2 C96.2
9875 Chronic myelogenous 207.8_ C94.3 C94.3_
205.1_ C92.1 C92.1_
leukemia, BCR/ABL1 positive
9950 Polycythemia vera 238.4 D45 D45
Myeloproliferative Neoplasms
(Table B1)
ICD-O-3 Code and Histology ICD-9- ICD- ICD-
CM 10 10-CM
9960 Chronic myeloproliferative 238.79 D47.1 D47.1
disease, NOS 238.76
238.71 D47.1 D47.4
9961 Myelosclerosis with myeloid
metaplasia D47.3 D47.3
D47.1 D47.1
9962 Essential thrombocythemia C94.7 C94.8_
9963 Chronic neutrophilic leukemia 205.1_
9964 Chronic eosinophilic leukemia, 207.8_
NOS
Myeloid and lymphoid neoplasms 2/21/2012
with PDGFRA rearrangement 20
(Table B2)
ICD-O-3 Code and Histology ICD-9- ICD- ICD-
CM 10 10-CM
9965 Myeloid and lymphoid
neoplasms with PDGFRA 238.79 D47.7 D47.Z9
rearrangement
238.79 D47.7 D47.Z9
9966 Myeloid neoplasms with 238.79 D47.7 D47.Z9
PDGFRB rearrangement
9967 Myeloid and lymphoid
neoplasms with FGFR1
abnormalities
Myelodysplastic/ Myeloproliferative
Neoplasms (B3)
ICD-O-3 Code and Histology ICD-9- ICD- ICD-
CM 10 10-CM
9876 Atypical chronic myeloid 205.1_ C92.1 C92.2_
leukemia, BCR-ABL1 negative
9945 Chronic myelomonocytic 205.1_ C92.1 C93.1_
leukemia
9946 Juvenile myelomonocytic 205.1_ C92.1 C93.3_
leukemia
9975 Myelodysplastic/myeloprolifera 238.79 D47.7 C94.6_;
tive neoplasm unclassifiable D47.1
Myelodysplastic Syndromes
(Table B4)
ICD-O-3 Code and Histology ICD-9- ICD- ICD-
CM 10 10-CM
9980 Refractory anemia 238.72 D46.4 D46.4
D46.1 D46.1
9982 Refractory anemia with ring 238.72 D46.2
D46.7 D46.2_
sideroblasts D46.7
D46.A,
9983 Refractory anemia with excess 238.73 D46.B
D46.C
blasts
9985 Refractory cytopenia with 238.72
multilineage dysplasia
9986 Myelodysplastic syndrome 238.74
associated with isolated del
(5q)
Myelodysplastic Syndromes 2/21/2012
(Table B4) 21
ICD-O-3 Code and Histology ICD-9- ICD- ICD-
CM 10 10-CM
9987 Therapy-related 238.77 D47.7 D47.Z1
myelodysplastic syndrome,
NOS 238.75 D46.9 C94.6_;
D46.9,
9989 Myelodysplastic syndrome, D46.Z
unclassifiable
238.72 D46.0 D46.0
9991 Refractory neutropenia 238.72 D46.0 D46.0
9992 Refractory thrombocytopenia
Acute Myeloid Leukemia (AML)
and Related Precursors(Table B5)
ICD-O-3 Code and Histology ICD-9- ICD- ICD-
CM 10 10-CM
9727 Blastic plasmacytoid dendritic 202.9_ C96.7 C86.4,
cell neoplasm 207.0_ C94.0 C96.4
205.9_ C92.9 C94.0_
9840 Acute erythroid leukemia 205.0_ C92.0
9860 Myeloid leukemia, NOS 205.1_ C92.1 C92.9_;
C93.9_
9861 Acute myeloid leukemia, NOS 205.0_ C92.0 C92.0_
9863 Chronic myeloid leukemia,
C92.1_;
NOS C92.2_;
C92.9_
9865 Acute myeloid leukemia with C92.0_
t(6;9)(p23;q34);DEK-NUP214
Acute Myeloid Leukemia (AML)
and Related Precursors(Table B5)
ICD-O-3 Code and Histology ICD-9- ICD-10 ICD-10-
CM CM
9866 Acute promyelocytic leukemia
(AML with t(15;17)(q22;q12)) 205.0_ C92.4 C92.4_
PML/RARA
205.0_ C92.5 C92.5_
9867 Acute myelomonocytic leukemia 205.0_ C92.0 C92.0_
9869 Acute myeloid leukemia with 205.0_ C92.0 C94.8_
inv(3)(q21;q26.2) or 205.0_ C92.0 C92.0_
t(3;3)(q21;q26.2); RPN1-EVI1
205.0_ C92.0 C92.0_
9870 Acute basophilic leukemia
9871 Acute myeloid leukemia with
inv(16)(p13.1q22) or t(16;16)
(p13.1;q22), CBFB/MYH11
9872 Acute myeloid leukemia with
minimal differentiation
Acute Myeloid Leukemia (AML) 2/21/2012
and Related Precursors(Table B5) 22
ICD-O-3 Code and Histology ICD-9- ICD-10 ICD-10-
CM CM
9873 Acute myeloid leukemia without 205.0_ C92.0 C92.0_
maturation 205.0_ C92.0 C92.0_
206.0_ C93.0 C93.0_
9874 Acute myeloid leukemia with 205.0_ C92.0 C92.A_
maturation 205.0_ C92.0 C92.0_
205.0_ C92.0 C92.6_
9891 Acute monnoblastic and
monocytic leukemia
9895 Acute myeloid leukemia with
myelodysplasia-related changes
9896 Acute myeloid leukemia,
t(8;21)(q22;q22) RUNX1-RUNX1T1
9897 Acute myeloid leukemia with
t(9;11)(p22;q23);MLLT3-MLL
Acute Myeloid Leukemia (AML)
and Related Precursors(Table B5)
ICD-O-3 Code and Histology ICD-9- ICD-10 ICD-10-
CM CM
9898 Myeloid leukemia associated with 205.8_ 205.8_ C92.Z_
Down Syndrome 207.2_ C94.2_
205.0_ C92.0_
9910 Acute megakaryoblastic leukemia 207.2_
205.0_ C92.0_
9911 Acute myeloid leukemia 205.0_ 205.3_ C92.3_
(megakaryoblastic) with 205.0_ 238.79 C94.4_
t(1;22)(p13;q13);RBM15-MKL1
9920 Therapy related myeloid neoplasm
9930 Myeloid sarcoma 205.3_
238.79
9931 Acute panmyelosis with
myelofibrosis
Acute Leukemia of Ambiguous
Terminology (Table B6)
ICD-O-3 Code and Histology ICD-9- ICD-10 ICD-10-
CM CM
9800 Leukemia, NOS C95.9
208.9_ C95.1_;
9801 Acute undifferentiated leukemia C95.0 C95.9_
9805 Acute biphenotypic leukemia 208.0_ C95.0 C95.0_
9806 Mixed phenotype acute leukemia 208.0_ C95.0
208.0_ C95.0_
with t(9;22)(q34;q11.2);BCR-ABL1
C95.0_
9807 Mixed phenotype acute leukemia
with t(v;11q23); MLL rearranged 208.0_ C95.0 C95.0_
208.0_ C95.0 C95.0_
9808 Mixed phenotype acute leukemia, 208.0_ C95.0 C95.0_
B/myeloid, NOS
9809 Mixed phenotype acute leukemia,
T/myeloid, NOS
Precursor Lymphoid Neoplasm 2/21/2012
(Table B7) 23
ICD-O-3 Code and Histology ICD-9- ICD-10 ICD-10-
CM C83.5 CM
9728 Precursor B lymphoblastic
lymphoma 200.1_ C83.5_
9729 Precursor T-cell lymphoblastic 200.1_ C83.5 C83.5_
lymphoma, NOS
204.8_ C91.7 C91.Z_
9811 B lymphoblastic
leukemia/lymphoma, NOS 204.8_ C91.7 C91.Z_
9812 B Lymphoblastic
leukemia/lymphoma with
t(9;22)(q34;q11.2); BCR-ABL1
Precursor Lymphoid Neoplasm
(Table B7)
ICD-O-3 Code and Histology ICD-9- ICD-10 ICD-10-
CM C91.7 CM
9813 B Lymphoblastic
leukemia/lymphoma with 204.8_ C91.Z_
t(v;11q23); MLL rearranged
204.8_ C91.7 C91.Z_
9814 B Lymphoblastic
leukemia/lymphoma with 204.8_ C91.7 C91.Z_
t(12;21)(p13;q22); TEL-AML1 204.8_ C91.7 C91.Z_
(ETV6-RUNX1
9815 B Lymphoblastic
leukemia/lymphoma with
hyperdiploidy
9816 B Lymphoblastic
leukemia/lymphoma with
hypodiploidy (Hypodiploid ALL)
Precursor Lymphoid Neoplasm
(Table B7)
ICD-O-3 Code and Histology ICD-9- ICD-10 ICD-10-
CM C91.7 CM
9817 B Lymphoblastic
leukemia/lymphoma with 204.8_ C91.7 C91.Z_
t(5;14)(q31;q32); IL3-IGH
204.8_ C91.0 C91.Z_
9818 B Lymphoblastic C91.0
leukemia/lymphoma with t(1;19) 204.0_ C91.7 C91.0_
(q23;p13.3);E2A-PBX1 (TCF3-PBX1 204.0_ C91.0_
204.8_ C91.Z_
9835 Precursor cell lymphoblastic
leukemia, NOS
9836 Precursor B-cell lymphoblastic
leukemia
9837 Adult T-cell leukemia/lymphoma
Mature B-Cell Neoplasms (Table B8) 2/21/2012
24
ICD-O-3 Code and Histology ICD-9- ICD-10 ICD-10-
CM CM
C85.9
9590 Malignant lymphoma 202.8_ C85.9 C85.9_
C85.9 C85.1_,
9591 Malignant lymphoma, non-Hodgkin, 202.8_ C85.7 C85.9_
C83.0 C85.9_
NOS C83.0
C83.1 C82.6_
9596 Composite Hodgkin and non- 202.8_
C83.0_
Hodgkin lymphoma
C83.0_
9597 Primary cutaneous follicle centre 202.0_
C83.1_
lymphoma
9670 Malignant lymphoma, small B 200.8_
lymphocytic, NOS
9671 Malignant lymphoma, 200.8_
lymphoplasmacytic
9673 Mantle cell lymphoma (MCL) 200.4_
Mature B-Cell Neoplasms (Table B8)
ICD-O-3 Code and Histology ICD-9- ICD-10 ICD-10-
CM CM
C83.8
9678 Primary effusion lymphoma 200.8_ C83.3 C83.8_
C83.3 C85.2_
9679 Mediastinal large B-cell lymphoma 200.7_ C83.3_
C83.3
9680 Malignant lymphoma, large B-cell, 200.7_ C83.3_
diffuse, NOS 200.8_ C83.7
200.2_ C83.3 C83.7_
9684 Malignant lymphoma, large B-cell C83.3_
diffuse, immunoblastic, NOS C83.0
C83.0_
9687 Burkitt lymphoma, NOS
9688 T-cell/histiocyte-rich large B-cell 200.7_
lymphoma 200.3_
9689 Splenic marginal zone B-cell
lymphoma
Mature B-Cell Neoplasms (Table B8)
ICD-O-3 Code and Histology ICD-9- ICD-10 ICD-10-
CM CM
9690 Follicular lymphomas, NOS C82.9
202.0_ C82.1 C82.8_;
9691 Follicular lymphoma, grade 2 C82.0 C82.9_
9695 Follicular lymphoma, grade 1 202.0_ C82.2 C82.1_
9698 Follicular lymphoma, grade 3 202.0_
202.0_ C85.1 C82.0_
9699 Marginal zone B-cell lymphoma, C83.8
NOS 200.3_ C82.2_;
C82.3_;
9712 Intravascular large B-cell 200.7_ C82.4_
lymphoma C83.0_;
C88.4
C83.8_
Mature B-Cell Neoplasms (Table B8) 2/21/2012
25
ICD-O-3 Code and Histology ICD-9- ICD-10 ICD-10-
CM CM
C90.2
9731 Solitary plasmactyoma of bone 203.8_ C90.0 C90.3_
C90.2 C90.0_
9732 Multiple Myeloma 203.0_ C83.3 C90.2_
C83.3 C83.3_
9734 Extraosseous plasmacytoma 203.8_ C85.7 C84.6_
C85.8_
9735 Plasmablastic lymphoma 200.7_
9737 Alk positive large B-cell lymphoma 200.6_
9738 Large B-cell lymphoma arising in 202.8_
HHVS-associated multicentric
Castleman disease
Mature B-Cell Neoplasms (Table B8)
ICD-O-3 Code and Histology ICD-9- ICD-10 ICD-10-
CM CM
9761 Waldenstrom Macroglobulinemia C88.0
9762 Heavy chain disease 273.3 C88.2 C88.0
9820 Lymphoid, leukemia, NOS 203.8_ C91.9 C88.2
9823 Chronic lymphocytic 204.9_ C91.1 C91.9_
204.1_ C91.1_
leukemia/small lymphocytic
lymphoma 204.8_ C91.7 C91.A_
9826 Burkitt cell leukemia 204.8_ C91.3 C91.3_
9832 Prolymphocytic leukemia, NOS 204.8_ C91.3 C91.3_
9833 B-cell prolymphocytic leukemia 202.4_ C91.4 C91.4_
9940 Hairy cell leukemia
Mature T-Cell and NK-Cell
neoplasms (Table B9)
ICD-O-3 Code and Histology ICD-9- ICD-10 ICD-10-
CM CM
9700 Mycosis Fungoides C84.0
9701 Sezary syndrome 202.1_ C84.1 C84.0_
9702 Mature T-cell lymphoma, NOS 202.2_ C84.4
202.7_ C84.1_
9705 Angioimmunoblastic T-cell C84.4
lymphoma 202.7_ C84.4_;
C84.7
9708 Subcutaneous panniculitis-like T- C86.5
cell lymphoma
202.8_ C84.5 C86.3
9709 Cutaneous T-cell lymphoma, NOS
202.8_ C84.5 C84.A_
Mature T-Cell and NK-Cell 2/21/2012
neoplasms (Table B9) 26
ICD-O-3 Code and Histology ICD-9- ICD-10 ICD-10-
CM CM
9714 Anaplastic large cell lymphoma, T
cell and Null cell type 200.6_ C83.3 C84.Z_
9716 Hepatosplenic T-cell lymphoma 202.8_ C84.5 C86.1
202.8_ C84.5 C86.2
9717 Enteropathy-associated T-cell
lymphoma 202.7_ C84.4 C86.6
9718 Primary cutaneous CD30-positive 202.8_ C84.5 C86.0
T-cell lymphoproliferative
disorders
9719 Extranodal NK/T cell lymphoma,
nasal type
Mature T-Cell and NK-Cell
neoplasms (Table B9)
ICD-O-3 Code and Histology ICD-9- ICD-10 ICD-10-
CM CM
C96.7
9724 Systemic EBV-positive T-cell 202.9_ C96.Z_
9725 lymphoproliferative disease of 202.8_ C85.7
childhood C84.4 C85.8_
Hydro vacciniforme-like lymphoma C91.5 C84.A_;
C91.7 C84.4_
9726 Primary cutaneous gamma delta T- 202.7_ C91.3 C91.5_
9827 cell lymphoma 204.8_ C94.7
9831 Adult T-cell leukemia/ lymphoma 204.8_ C91.Z_
9834 (HTLV-1 positive) 204.8_
T-cell large granular lymphocytic C91.6_
leukemia C94.8_
T-cell prolymphocytic leukemia
9948 Aggressive NK-cell leukemia 207.8_
Hodgkin Lymphoma (Table B10)
ICD-O-3 Code and Histology ICD-9- ICD- ICD-10-
CM 10 CM
9650 Hodgkin Lymphoma, NOS
201.9_ C81.3 C81.7;
9651 Hodgkin lymphoma, lymphocyte-rich C81.9_
201.4_ C81.7 C81.4_
9652 Hodgkin lymphoma, mixed cellularity, NOS 201.6_ C81.2
201.7_ C81.3 C81.2_
9653 Hodgkin lymphoma, lymphocyte depletion,
NOS C81.3_
9654 Hodgkin lymphoma, lymphocytic depletion, 201.7_ C81.3 C81.3_
diffuse fibrosis
201.7_ C81.3 C81.3_
9655 Hodgkin lymphoma, lymphocyte depletion,
reticular
Hodgkins Lymphoma (Table B10) 2/21/2012
27
ICD-O-3 Code and Histology ICD-9- ICD- ICD-10-
CM 10 CM
9659 Hodgkin lymphoma, nodular lymphocyte
predominance 201.4_ C81.0 C81.0_
9663 Hodgkin lymphoma, nodular sclerosis, NOS 201.5_ C81.1 C81.1_
201.5_ C81.1 C81.1_
9664 Hodgkin lymphoma, nodular sclerosis,
9665 cellular phase 201.5_ C81.1 C81.1_
9667 Hodgkin lymphoma, nodular sclerosis,
grade I 201.5_ C81.1 C81.1_
Hodgkin lymphoma, nodular sclerosis,
grade 2
Histiocytic and Dendritic Cell
Neoplasms(Table B11)
ICD-O-3 Code and Histology ICD-9- ICD- ICD-10-
CM 10 CM
9751 Langerhans cell histiocytosis
9754 Langerhans' cell histiocytosis, 202.5_ C96.0 C96.0
disseminated 202.5_ C96.0 C96.0
9755 Histiocytic sarcoma
9756 Langerhans cell sarcoma 202.9_ C96.7 C96.A
9757 Interdigitating dendritic cell sarcoma 202.9_ C96.7 C96.4
9758 Follicular dendritic cell sarcoma 202.9_ C96.7 C96.4
9759 Fibroblastic reticular cell tumor 202.9_ C96.7 C96.4
202.9_ C96.7 C96.4
Post-Transplant
Lymphoproliferative Disorder
(PTLD) (Table B12)
ICD-O-3 Code and Histology ICD-9- ICD- ICD-10-
CM 10 CM
9971 Polymorphic Post Transplant
Lymphoproliferative Disorder (PTLD) 238.77 D47.7 D47.Z1
Review of 2/21/2012
Hematopoietic coding 28
A review of primary site/histology
coding from the Hematopoietic
Database
Coding guidelines
Table B1: Myeloproliferative
Neoplasms
• Histologies: 9742, 9875, 9950, 9961,
9962, 9963, 9964, 9975
• Primary site ALWAYS coded C42.1
• CS Extension=800
• Summary Stage=7
Coding guidelines
Table B2: Myeloid and Lymphoid
Neoplasms with Eosinophilia and
Abnormalities of PDGFRA, PDFFRB
or FGFR1
• Histologies: 9965, 9966, 9967
• Histologies effective 1/1/2010
• Primary site ALWAYS coded C42.1
• CS Extension=800
• Summary Stage=7
Coding guidelines 2/21/2012
29
Table B3: Myelodysplastic/
Myeloproliferative Neoplasms
• Histologies: 9876, 9945, 9946, 9975
• Primary site ALWAYS coded C42.1
• CS Extension=800
• Summary Stage=7
Coding guidelines
Table B4: Myelodysplastic
syndromes
• Histologies: 9980, 9982, 9983, 9985,
9986, 9989, 9991, 9992
• Primary site ALWAYS coded C42.1
• Histologies 9991 and 9992 effective
1/1/2010
• CS Extension=800
• Summary Stage=7
Coding guidelines
Table B4: Myelodysplastic
syndromes
• 9987: Therapy-related myelodysplastic
syndrome, NOS [OBS]
– No longer applicable starting in 2010
• See code 9920: Therapy related myeloid
neoplasm
Coding guidelines 2/21/2012
30
Table B5: AML and Related Precursor
Neoplasms
• Histologies: 9727, 9840, 9861, 9865, 9869, 9870-
9874, 9891-9898, 9910, 9911, 9920, 9931
• Primary site ALWAYS coded C42.1
• Histologies 9865, 9869, 9898, 9911 effective
1/1/2010
• CS Extension=800
• Summary Stage=7
Coding guidelines
Table B6: Acute Leukemia of
ambiguous lineage
• Histologies: 9801, 9805-9809
• Primary site ALWAYS coded C42.1
• Histologies 9806-9809 effective 1/1/2010
• Histology 9805 OBSOLETE as of 1/1/2010
• CS Extension=800
• Summary Stage=7
Coding guidelines
Table B7: Precursor Lymphoid
Neoplasms
• Histologies: 9811-9818, 9837
• Histologies 9811-9818 effective 1/1/2010
• CS Schemas: Lymphoma, Lymphoma
Ocular Adnexa or HemeRetic depending
on primary site
– Usually leukemia (HemeRetic schema)
Coding guidelines 2/21/2012
31
Table B8: Mature B-Cell Neoplasms
• Primary site based on presentation for
most lymphomas
• If you have a lymphoma with only evidence
in bone marrow:
– Code primary site C42.1 (Bone Marrow)
– CS Extension=800
– Summary Stage=7
Coding guidelines
Table B8: Mature B-Cell Neoplasms
• Primary site based on presentation for
most lymphomas
• 9596: B-cell lymphoma, unclassifiable
– Primary Site C77.0-C77.9 (lymph nodes)
• 9597: Primary cutaneous follicle centre
lymphoma
– Primary Site C44.0-C44.9 (skin)
Coding guidelines
Table B8: Mature B-Cell Neoplasms
• 9688: T-cell/histiocytic rich large B-cell
lymphoma
– Primary Site C44.0-C44.9 (skin)
• 9689: Splenic marginal zone lymphoma
– Primary Site C42.2 (Spleen)
– Note: 9699 (Extranodal marginal zone
lymphoma) should NOT be coded to C42.2
Coding guidelines 2/21/2012
32
Table B8: Mature B-Cell Neoplasms
• 9731: Solitary plasmacytoma of bone
– Primary site MUST be C40.0-C41.9
– CS Extension MUST be 110, 200, 400, 500 or 999
– CS Lymph Nodes and Mets are 988
– Summary Stage applicable for codes 1, 7, 9
• 9734: Extraosseous plasmacytoma
– Primary site CANNOT be coded to C40.0-C41.9
– CS Extension MUST be 300, 400, 999
– CS Lymph nodes applicable
– Summary Stage applicable for code 1-9
Coding guidelines
Table B8: Mature B-Cell Neoplasms
• 9732: Multiple Myeloma
– Primary site MUST be C42.1
– CS Extension MUST be 810 or 820
– CS Lymph Nodes and Mets=988
– Summary Stage MUST be 7
• 9733: Plasma cell leukemia
– Per new rules (to be release 4/2012), Plasma cell
leukemia is to be coded as Multiple Myeloma
(9732)
Coding guidelines
Table B8: Mature B-Cell Neoplasms
• 9761: Waldenstrom Macroglobulinemia
– Primary Site C42.0 (Blood)
– CS Extension=800, Summary Stage=7
• 9940: Hairy Cell Leukemia
– Primary Site C42.1
– Collected in HemeRetic schema
– CS Extension=800, Summary Stage=7
– Hairy Cell Leukemia variant coded to 9591/3
Coding guidelines 2/21/2012
33
Table B9: Mature T-Cell and NK-Cell
Neoplasms
• Skin associated lymphomas (C44.0-C44.9)
– 9700, 9701, 9709, 9725
• 9708: Subcutaneous panniculitis-like T-
cell lymphoma
– Primary sites C49.0-C49.9
• 9726: Primary cutaneous gamma-delta T-
cell lymphoma
– Primary sites include C44.0-C44.9, C49.0-C49.9
Coding guidelines
Table B9: Mature T-Cell and NK-Cell
Neoplasms
• 9716: Hepatosplenic T-cell lymphoma
– Primary site C42.2 (Spleen)
• 9827: Adult T-cell leukemia/lymphoma
– Primary site C77.0-C77.9 (Lymphoma schema)
– Primary site C42.1 (HemeRetic schema)
• 9831 and 9948: Leukemias
– Primary site C42.1
Coding guidelines
Table B10: Hodgkin’s lymphomas
• Histologies: 9650, 9651, 9652, 9653, 9654,
9655, 9659, 9663, 9664, 9665, 9667
• Predominantly involves lymph nodes
• Primary rarely in extranodal sites
• Default primary sites: C77.0-C77.9
Coding guidelines 2/21/2012
34
Table B11: Histiocytic and Dendritic
Cell Neoplasms
• Histologies: 9751, 9755-9759
– Note: Histologies 9752, 9753 and 9754 are no
longer used and should be coded as 9751/3.
• Collected in HemeRetic schema
• Applicable CS Extension codes:
– 100: Localized
– 800: Systemic
– 999: Unknown
Coding guidelines
Table B12: Post-Transplant
Lymphoproliferative Disorders
(PTLD)
• No default primary site
• Refer to abstractor notes for instructions
on coding primary site
Recent News: 2/16/12
HHS Announces Intent to Delay ICD-10
Compliance Date:
“As part of President Obama’s commitment to
reducing regulatory burden, Health and Human
Services Secretary Kathleen G. Sebelius today
announced that HHS will initiate a process to
postpone the date by which certain health care
entities have to comply with International
Classification of Diseases, 10th Edition diagnosis
and procedure codes (ICD-10).”
http://www.hhs.gov/news/press/2012pres/02/20120216a.html
ICD-10-CM Workgroup response: 2/21/2012
35
NCRA webinars to continue as
planned (including May webinar)
Current and planned work to
continue until a new
implementation date set
ICD-10-CM Workgroup response:
If delay is only till 2014, no
change in planned work, schedule
If delay is beyond 2014, group will
meet to decide on how to go
forward
AHIMA Response
Does not support delay
Reiterates that this release does
not say ICD-10-CM delay will
happen
No comment on changes to CEU
requirements
http://www.ahima.org/downloads/pdfs/pr/press-
releases/Continue_Call_for_Progress_in_ICD.pdf
2/21/2012
Resources
Link to Classifications of Diseases,
Functioning and Disability (ICD
coding systems)
http://www.cdc.gov/nchs/icd.htm
Contact
Jennifer Ruhl, RHIT, CCS, CTR
301-594-8494
[email protected]
Jennifer Ruhl is a Public Health Analyst for the
National Cancer Institute’s Surveillance, Epidemiology
and End Results Program (NCI SEER). The findings and
conclusions in this presentation are those of the
author(s) and do not necessarily represent the official
position of NCI SEER.
36